Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial
JACC Heart Fail 2023 Oct 12;[EPub Ahead of Print], A Wang, JA Spertus, DM Wojdyla, TP Abraham, EK Nilles, AT Owens, S Saberi, S Cresci, A Sehnert, NK LakdawalaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.